FDA Approves Opus Genetics Eye Drops for Presbyopia
The approval expands use of an already commercialized therapy and triggers a milestone payment. The payment amount is not specified.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
FDA approves Opus Genetics’ phentolamine eye drops for presbyopia
The FDA approved phentolamine ophthalmic solution 0.75% for the treatment of presbyopia.